Entities in the healthcare space that engage independent sales representatives to promote their or others' products should be mindful of the regulatory considerations and risks associated with how those representatives are compensated. Kyle Faget and Larry Vernaglia from the HLN's sponsor firm, Foley & Lardner LLP, will discuss how such representatives are compensated, what risks are involved, and what steps you should consider to help ensure that those arrangements will withstand legal scrutiny.

Generously sponsored by Foley & Lardner LLP